CLINICAL_TRIALS
trial_result
· 2010-02-23
Clinical Trial Update: Study Of SU011248 In Combination With Docetaxel (Taxotere) And Prednisone In Patients With Prostate Cancer [Phase 1, Phase 2]
Summary
Phase 1/2 trial evaluating SU011248 in combination with docetaxel and prednisone for prostate cancer has completed, with results posted in 2010.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Prostatic Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-02-23